HER2 signaling can also promote cell survival and colonization at distant metastatic sites, establishing secondary tumors. HER2-positive tumors have different clinicopathological features and ...

Dr. Sara M. Tolaney breaks down key takeaways from the DESTINY-Breast09 trial that patients with HER2+ advanced or metastatic ...

The chances of survival also depend on your age and general health. The fact that the cancer is positive for HER2 will affect your treatment and survival. Experts consider the HER2+ breast cancer ...

Treatments followed recommendations for female breast cancer, and overall survival was associated ... A total of 13.5% of tumors were HER2-positive. 1 Breast cancer was usually diagnosed at ...

Researchers evaluated current treatment patterns and clinical outcomes for patients with HER2-positive metastatic breast cancer.

Novartis Canada is pleased to announce that Health Canada has granted a Notice of Compliance (NOC) for KISQALI® (ribociclib ...

The following is a summary of "Advances and challenges in targeted therapies for HER2-amplified colorectal cancer," published in the April 2025 issue of the European Journal of Cancer by Pizzamiglio ...

Atezolizumab may improve upon perioperative treatment with trastuzumab and chemotherapy in HER2+, locally advanced, resectable gastric or GEJ cancer, researchers say.

AstraZeneca Plc (NASDAQ:AZN) on Monday released results from three Phase 3 clinical trials at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting: DESTINY-Breast09, MATTERHORN, and ...